- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-effectiveness analysis of introducing HTLV-1 testing in South Africa ; volume:12 ; number:1 ; day:28 ; month:8 ; year:2015 ; pages:1 ; date:12.2015
Retrovirology ; 12, Heft 1 (28.8.2015), 1, 12.2015
- Creator
-
Sykes, Wendy
Coleman, Charl
Beck, Genevieve
Mhlanga, Jabu
Hlela, Carol
Custer, Brian
Murphy, Edward L.
Vermeulen, Marion
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-12-S1-P81
- URN
-
urn:nbn:de:101:1-2020100521055051086591
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sykes, Wendy
- Coleman, Charl
- Beck, Genevieve
- Mhlanga, Jabu
- Hlela, Carol
- Custer, Brian
- Murphy, Edward L.
- Vermeulen, Marion
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Impact and cost-effectiveness of chlamydia testing in Scotland: a mathematical modelling study
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Cost-effectiveness of introducing cone-beam computed tomography (CBCT) in the management of complex phalangeal fractures: economic simulation
Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Impact and cost-effectiveness of chlamydia testing in Scotland: a mathematical modelling study
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Cost-effectiveness of introducing cone-beam computed tomography (CBCT) in the management of complex phalangeal fractures: economic simulation
Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico
Cost-effectiveness analysis of molecular testing for cytologically indeterminate thyroid nodules
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Pulmonary function testing in HTLV-I and HTLV-II infected humans: a cohort study
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
COVID-19 testing protocols to guide duration of isolation: a cost-effectiveness analysis
Impact and cost-effectiveness of chlamydia testing in Scotland: a mathematical modelling study
Costs and cost-effectiveness of HIV counselling and testing modalities in Southern Mozambique
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve